Category: Antibodies

Filter By
Brand: Leinco Clear all
Anti-Influenza A, Nucleocapsid (Clone 274) - 100 µg Anti-Influenza A, Nucleocapsid (Clone 274) - 100 µg

Anti-Influenza A, Nucleocapsid (Clone 274) - 100 µg

Reference: F613-100 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 274) - 500 µg Anti-Influenza A, Nucleocapsid (Clone 274) - 500 µg

Anti-Influenza A, Nucleocapsid (Clone 274) - 500 µg

Reference: F613-500 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 1078) - 100 µg Anti-Influenza A, Nucleocapsid (Clone 1078) - 100 µg

Anti-Influenza A, Nucleocapsid (Clone 1078) - 100 µg

Reference: F610-100 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 1078) - 500 µg Anti-Influenza A, Nucleocapsid (Clone 1078) - 500 µg

Anti-Influenza A, Nucleocapsid (Clone 1078) - 500 µg

Reference: F610-500 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 1114) - 100 µg Anti-Influenza A, Nucleocapsid (Clone 1114) - 100 µg

Anti-Influenza A, Nucleocapsid (Clone 1114) - 100 µg

Reference: F607-100 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 1114) - 500 µg Anti-Influenza A, Nucleocapsid (Clone 1114) - 500 µg

Anti-Influenza A, Nucleocapsid (Clone 1114) - 500 µg

Reference: F607-500 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 657) - 100 µg Anti-Influenza A, Nucleocapsid (Clone 657) - 100 µg

Anti-Influenza A, Nucleocapsid (Clone 657) - 100 µg

Reference: F604-100 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 657) - 500 µg Anti-Influenza A, Nucleocapsid (Clone 657) - 500 µg

Anti-Influenza A, Nucleocapsid (Clone 657) - 500 µg

Reference: F604-500 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 703) - 100 µg Anti-Influenza A, Nucleocapsid (Clone 703) - 100 µg

Anti-Influenza A, Nucleocapsid (Clone 703) - 100 µg

Reference: F601-100 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Influenza A, Nucleocapsid (Clone 703) - 500 µg Anti-Influenza A, Nucleocapsid (Clone 703) - 500 µg

Anti-Influenza A, Nucleocapsid (Clone 703) - 500 µg

Reference: F601-500 µg
€0.00 (tax incl.)
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is...
Anti-Human CD257 (BAFF) (Tabalumab) - Biotin - 100 µg Anti-Human CD257 (BAFF) (Tabalumab) - Biotin - 100 µg

Anti-Human CD257 (BAFF) (Tabalumab) - Biotin - 100 µg

Reference: LT1401-100 μg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted™ HRP - 100 µg Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted™ HRP - 100 µg

Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted™ HRP - 100 µg

Reference: LT1407-100 μg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - Custom Anti-Human CD257 (BAFF) (Tabalumab) - Custom

Anti-Human CD257 (BAFF) (Tabalumab) - Custom

Reference: LT1400-Custom
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - 50 mg Anti-Human CD257 (BAFF) (Tabalumab) - 50 mg

Anti-Human CD257 (BAFF) (Tabalumab) - 50 mg

Reference: LT1400-50 mg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - 5.0 mg Anti-Human CD257 (BAFF) (Tabalumab) - 5.0 mg

Anti-Human CD257 (BAFF) (Tabalumab) - 5.0 mg

Reference: LT1400-5 mg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - 25 mg Anti-Human CD257 (BAFF) (Tabalumab) - 25 mg

Anti-Human CD257 (BAFF) (Tabalumab) - 25 mg

Reference: LT1400-25 mg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - 100 mg Anti-Human CD257 (BAFF) (Tabalumab) - 100 mg

Anti-Human CD257 (BAFF) (Tabalumab) - 100 mg

Reference: LT1400-100 mg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - 1.0 mg Anti-Human CD257 (BAFF) (Tabalumab) - 1.0 mg

Anti-Human CD257 (BAFF) (Tabalumab) - 1.0 mg

Reference: LT1400-1 mg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - Dylight® 488 - 100 µg Anti-Human CD257 (BAFF) (Tabalumab) - Dylight® 488 - 100 µg

Anti-Human CD257 (BAFF) (Tabalumab) - Dylight® 488 - 100 µg

Reference: LT1411-100 μg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human CD257 (BAFF) (Tabalumab) - PE - 50 µg Anti-Human CD257 (BAFF) (Tabalumab) - PE - 50 µg

Anti-Human CD257 (BAFF) (Tabalumab) - PE - 50 µg

Reference: LT1404-50 μg
€0.00 (tax incl.)
Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that...
Anti-Human IL-6 (Sarilumab) - Fc Muted™ HRP - 100 µg Anti-Human IL-6 (Sarilumab) - Fc Muted™ HRP - 100 µg

Anti-Human IL-6 (Sarilumab) - Fc Muted™ HRP - 100 µg

Reference: LT1707-100 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - Fc Muted™ Biotin - 100 µg Anti-Human IL-6 (Sarilumab) - Fc Muted™ Biotin - 100 µg

Anti-Human IL-6 (Sarilumab) - Fc Muted™ Biotin - 100 µg

Reference: LT1706-100 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ HRP - 100 µg Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ HRP - 100 µg

Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ HRP - 100 µg

Reference: LT1607-100 μg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ Biotin - 100 µg Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ Biotin - 100 µg

Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ Biotin - 100 µg

Reference: LT1606-100 μg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human IL-6 (Sarilumab) - Custom Anti-Human IL-6 (Sarilumab) - Custom

Anti-Human IL-6 (Sarilumab) - Custom

Reference: LT1700-Custom
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - 100 mg Anti-Human IL-6 (Sarilumab) - 100 mg

Anti-Human IL-6 (Sarilumab) - 100 mg

Reference: LT1700-100 mg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human CTLA-4 (Ipilimumab) - Custom Anti-Human CTLA-4 (Ipilimumab) - Custom

Anti-Human CTLA-4 (Ipilimumab) - Custom

Reference: LT1600-Custom
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - 50 mg Anti-Human CTLA-4 (Ipilimumab) - 50 mg

Anti-Human CTLA-4 (Ipilimumab) - 50 mg

Reference: LT1600-50 mg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - 5.0 mg Anti-Human CTLA-4 (Ipilimumab) - 5.0 mg

Anti-Human CTLA-4 (Ipilimumab) - 5.0 mg

Reference: LT1600-5 mg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - 25 mg Anti-Human CTLA-4 (Ipilimumab) - 25 mg

Anti-Human CTLA-4 (Ipilimumab) - 25 mg

Reference: LT1600-25 mg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - 100 mg Anti-Human CTLA-4 (Ipilimumab) - 100 mg

Anti-Human CTLA-4 (Ipilimumab) - 100 mg

Reference: LT1600-100 mg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human IL-6 (Sarilumab) - 50 mg Anti-Human IL-6 (Sarilumab) - 50 mg

Anti-Human IL-6 (Sarilumab) - 50 mg

Reference: LT1700-50 mg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human CTLA-4 (Ipilimumab) - 1.0 mg Anti-Human CTLA-4 (Ipilimumab) - 1.0 mg

Anti-Human CTLA-4 (Ipilimumab) - 1.0 mg

Reference: LT1600-1 mg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - Biotin - 100 µg Anti-Human CTLA-4 (Ipilimumab) - Biotin - 100 µg

Anti-Human CTLA-4 (Ipilimumab) - Biotin - 100 µg

Reference: LT1601-100 μg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human CTLA-4 (Ipilimumab) - HRP - 100 µg Anti-Human CTLA-4 (Ipilimumab) - HRP - 100 µg

Anti-Human CTLA-4 (Ipilimumab) - HRP - 100 µg

Reference: LT1602-100μg
€0.00 (tax incl.)
Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) is a protein receptor that serves as an immune checkpoint and down-regulates the immune system. CTLA-4 is constitutively expressed in regulatory T cells but is only...
Anti-Human IL-6 (Sarilumab) Dylight® 488 - 100 µg Anti-Human IL-6 (Sarilumab) Dylight® 488 - 100 µg

Anti-Human IL-6 (Sarilumab) Dylight® 488 - 100 µg

Reference: LT1711-100 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - PE - 50 µg Anti-Human IL-6 (Sarilumab) - PE - 50 µg

Anti-Human IL-6 (Sarilumab) - PE - 50 µg

Reference: LT1704-50 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - APC - 50 µg Anti-Human IL-6 (Sarilumab) - APC - 50 µg

Anti-Human IL-6 (Sarilumab) - APC - 50 µg

Reference: LT1703-50 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - HRP - 100 µg Anti-Human IL-6 (Sarilumab) - HRP - 100 µg

Anti-Human IL-6 (Sarilumab) - HRP - 100 µg

Reference: LT1702-100 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human IL-6 (Sarilumab) - Biotin - 100 µg Anti-Human IL-6 (Sarilumab) - Biotin - 100 µg

Anti-Human IL-6 (Sarilumab) - Biotin - 100 µg

Reference: LT1701-100 μg
€0.00 (tax incl.)
IL-6 and its signaling pathway play a part in immune response regulation, inflammation, and hematopoiesis.2 Sarilumab is a research-grade recombinant human monoclonal IL-6 receptor antagonist. It specifically binds...
Anti-Human OX40L (Oxelumab) - Custom Anti-Human OX40L (Oxelumab) - Custom

Anti-Human OX40L (Oxelumab) - Custom

Reference: LT1300-Custom
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - 50 mg Anti-Human OX40L (Oxelumab) - 50 mg

Anti-Human OX40L (Oxelumab) - 50 mg

Reference: LT1300-50 mg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - 5.0 mg Anti-Human OX40L (Oxelumab) - 5.0 mg

Anti-Human OX40L (Oxelumab) - 5.0 mg

Reference: LT1300-5 mg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - 25 mg Anti-Human OX40L (Oxelumab) - 25 mg

Anti-Human OX40L (Oxelumab) - 25 mg

Reference: LT1300-25 mg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - 100 mg Anti-Human OX40L (Oxelumab) - 100 mg

Anti-Human OX40L (Oxelumab) - 100 mg

Reference: LT1300-100 mg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human CD11a (Efalizumab) - Fc Muted™ - Custom Anti-Human CD11a (Efalizumab) - Fc Muted™ - Custom

Anti-Human CD11a (Efalizumab) - Fc Muted™ - Custom

Reference: LT805-Custom
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - Fc Muted™ - 500 µg Anti-Human CD11a (Efalizumab) - Fc Muted™ - 500 µg

Anti-Human CD11a (Efalizumab) - Fc Muted™ - 500 µg

Reference: LT805-500 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human OX40L (Oxelumab) - Dylight® 488 - 100 µg Anti-Human OX40L (Oxelumab) - Dylight® 488 - 100 µg

Anti-Human OX40L (Oxelumab) - Dylight® 488 - 100 µg

Reference: LT1311-100 μg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - PE - 50 µg Anti-Human OX40L (Oxelumab) - PE - 50 µg

Anti-Human OX40L (Oxelumab) - PE - 50 µg

Reference: LT1304-50 μg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human OX40L (Oxelumab) - APC - 50 µg Anti-Human OX40L (Oxelumab) - APC - 50 µg

Anti-Human OX40L (Oxelumab) - APC - 50 µg

Reference: LT1303-50 μg
€0.00 (tax incl.)
Oxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The...
Anti-Human CD11a (Efalizumab) - Fc Muted™ HRP - 100 µg Anti-Human CD11a (Efalizumab) - Fc Muted™ HRP - 100 µg

Anti-Human CD11a (Efalizumab) - Fc Muted™ HRP - 100 µg

Reference: LT807-100 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - Fc Muted™ Biotin - 100 µg Anti-Human CD11a (Efalizumab) - Fc Muted™ Biotin - 100 µg

Anti-Human CD11a (Efalizumab) - Fc Muted™ Biotin - 100 µg

Reference: LT806-100 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - Custom Anti-Human CD11a (Efalizumab) - Custom

Anti-Human CD11a (Efalizumab) - Custom

Reference: LT800-Custom
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - 100 mg Anti-Human CD11a (Efalizumab) - 100 mg

Anti-Human CD11a (Efalizumab) - 100 mg

Reference: LT800-100 mg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - 50 mg Anti-Human CD11a (Efalizumab) - 50 mg

Anti-Human CD11a (Efalizumab) - 50 mg

Reference: LT800-50 mg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - Dylight® 488 - 50 µg Anti-Human CD11a (Efalizumab) - Dylight® 488 - 50 µg

Anti-Human CD11a (Efalizumab) - Dylight® 488 - 50 µg

Reference: LT811-50 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - PE - 50 µg Anti-Human CD11a (Efalizumab) - PE - 50 µg

Anti-Human CD11a (Efalizumab) - PE - 50 µg

Reference: LT804-50 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - APC - 50 µg Anti-Human CD11a (Efalizumab) - APC - 50 µg

Anti-Human CD11a (Efalizumab) - APC - 50 µg

Reference: LT803-50 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - HRP - 100 µg Anti-Human CD11a (Efalizumab) - HRP - 100 µg

Anti-Human CD11a (Efalizumab) - HRP - 100 µg

Reference: LT802-100 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD11a (Efalizumab) - Biotin - 100 µg Anti-Human CD11a (Efalizumab) - Biotin - 100 µg

Anti-Human CD11a (Efalizumab) - Biotin - 100 µg

Reference: LT801-100 μg
€0.00 (tax incl.)
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3,...
Anti-Human CD279 (PD-1) (Nivolumab) - Custom Anti-Human CD279 (PD-1) (Nivolumab) - Custom

Anti-Human CD279 (PD-1) (Nivolumab) - Custom

Reference: LT1200-Custom
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - 50 mg Anti-Human CD279 (PD-1) (Nivolumab) - 50 mg

Anti-Human CD279 (PD-1) (Nivolumab) - 50 mg

Reference: LT1200-50 mg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - 5.0 mg Anti-Human CD279 (PD-1) (Nivolumab) - 5.0 mg

Anti-Human CD279 (PD-1) (Nivolumab) - 5.0 mg

Reference: LT1200-5 mg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - 25 mg Anti-Human CD279 (PD-1) (Nivolumab) - 25 mg

Anti-Human CD279 (PD-1) (Nivolumab) - 25 mg

Reference: LT1200-25 mg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - 100 mg Anti-Human CD279 (PD-1) (Nivolumab) - 100 mg

Anti-Human CD279 (PD-1) (Nivolumab) - 100 mg

Reference: LT1200-100 mg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - 1.0 mg Anti-Human CD279 (PD-1) (Nivolumab) - 1.0 mg

Anti-Human CD279 (PD-1) (Nivolumab) - 1.0 mg

Reference: LT1200-1 mg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - Dylight® 488 - 100 µg Anti-Human CD279 (PD-1) (Nivolumab) - Dylight® 488 - 100 µg

Anti-Human CD279 (PD-1) (Nivolumab) - Dylight® 488 - 100 µg

Reference: LT1211-100 μg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - PE - 50 µg Anti-Human CD279 (PD-1) (Nivolumab) - PE - 50 µg

Anti-Human CD279 (PD-1) (Nivolumab) - PE - 50 µg

Reference: LT1204-50 μg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD279 (PD-1) (Nivolumab) - APC - 50 µg Anti-Human CD279 (PD-1) (Nivolumab) - APC - 50 µg

Anti-Human CD279 (PD-1) (Nivolumab) - APC - 50 µg

Reference: LT1203-50 μg
€0.00 (tax incl.)
Programmed cell death protein 1 (PD-1) is a protein on the surface of cells that plays a role in the maintenance of self-tolerance. PD-1 promotes self-tolerance via the down-regulation of the immune system which...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Custom Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Custom

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Custom

Reference: LT1100-Custom
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 50 mg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 50 mg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 50 mg

Reference: LT1100-50 mg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 5.0 mg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 5.0 mg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 5.0 mg

Reference: LT1100-5 mg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 25 mg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 25 mg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 25 mg

Reference: LT1100-25 mg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 100 mg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 100 mg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - 100 mg

Reference: LT1100-100 mg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - PE - 50 µg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - PE - 50 µg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - PE - 50 µg

Reference: LT1104-50 μg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - APC - 50 µg Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - APC - 50 µg

Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - APC - 50 µg

Reference: LT1103-50 μg
€0.00 (tax incl.)
Natalizumab is characterized as a disease-modifying therapy for multiple sclerosis (a disease of the central nervous system (CNS)), and inflammatory bowel disease. It works by inhibiting the migration of leukocytes to...
Anti-Human CD20 (Rituximab) - 100 mg Anti-Human CD20 (Rituximab) - 100 mg

Anti-Human CD20 (Rituximab) - 100 mg

Reference: LT900-100 mg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human CD20 (Rituximab) - 5 mg Anti-Human CD20 (Rituximab) - 5 mg

Anti-Human CD20 (Rituximab) - 5 mg

Reference: LT900-5.0 mg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human CD20 (Rituximab) - 50 mg Anti-Human CD20 (Rituximab) - 50 mg

Anti-Human CD20 (Rituximab) - 50 mg

Reference: LT900-50 mg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human CD20 (Rituximab) - Dylight® 488 - 100 µg Anti-Human CD20 (Rituximab) - Dylight® 488 - 100 µg

Anti-Human CD20 (Rituximab) - Dylight® 488 - 100 µg

Reference: LT911-100 μg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human CD20 (Rituximab) - PE - 50 mg Anti-Human CD20 (Rituximab) - PE - 50 mg

Anti-Human CD20 (Rituximab) - PE - 50 mg

Reference: LT904-50 μg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human CD20 (Rituximab) APC - 50 µg Anti-Human CD20 (Rituximab) APC - 50 µg

Anti-Human CD20 (Rituximab) APC - 50 µg

Reference: LT903-50μg
€0.00 (tax incl.)
CD20 is a 33-37 kD transmembrane-spanning phosphoprotein found on the surface of developing B-cells and various B-cell malignancies. CD20 is a popular target for mAb therapy because depleting developing B-cells...
Anti-Human DR5 (Drozitumab) - Fc Muted™ HRP - 100 µg Anti-Human DR5 (Drozitumab) - Fc Muted™ HRP - 100 µg

Anti-Human DR5 (Drozitumab) - Fc Muted™ HRP - 100 µg

Reference: LT707-100 μg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - Fc Muted™ Biotin - 100 µg Anti-Human DR5 (Drozitumab) - Fc Muted™ Biotin - 100 µg

Anti-Human DR5 (Drozitumab) - Fc Muted™ Biotin - 100 µg

Reference: LT706-100 μg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - Custom Anti-Human DR5 (Drozitumab) - Custom

Anti-Human DR5 (Drozitumab) - Custom

Reference: LT700-Custom
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - 50 mg Anti-Human DR5 (Drozitumab) - 50 mg

Anti-Human DR5 (Drozitumab) - 50 mg

Reference: LT700-50 mg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - 5.0 mg Anti-Human DR5 (Drozitumab) - 5.0 mg

Anti-Human DR5 (Drozitumab) - 5.0 mg

Reference: LT700-5 mg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - 25 mg Anti-Human DR5 (Drozitumab) - 25 mg

Anti-Human DR5 (Drozitumab) - 25 mg

Reference: LT700-25 mg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - 100 mg Anti-Human DR5 (Drozitumab) - 100 mg

Anti-Human DR5 (Drozitumab) - 100 mg

Reference: LT700-100 mg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - 1.0 mg Anti-Human DR5 (Drozitumab) - 1.0 mg

Anti-Human DR5 (Drozitumab) - 1.0 mg

Reference: LT700-1 mg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - Dylight® 488 - 100 µg Anti-Human DR5 (Drozitumab) - Dylight® 488 - 100 µg

Anti-Human DR5 (Drozitumab) - Dylight® 488 - 100 µg

Reference: LT711-100 μg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - PE - 50 µg Anti-Human DR5 (Drozitumab) - PE - 50 µg

Anti-Human DR5 (Drozitumab) - PE - 50 µg

Reference: LT704-50 μg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...
Anti-Human DR5 (Drozitumab) - APC - 50 µg Anti-Human DR5 (Drozitumab) - APC - 50 µg

Anti-Human DR5 (Drozitumab) - APC - 50 µg

Reference: LT703-50 μg
€0.00 (tax incl.)
Drozitumab is a monoclonal antibody that specifically binds to human DR5. DR5 is expressed in a variety of solid tumors and hematologic malignancies, which are characteristically resistant to apoptosis. Drozitumab is...

Menu

Settings

Please sign in first.

Sign in